Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study.

Herbert L DuvivierMichael RothePam K Mangat Elizabeth Garrett-MayerEugene R AhnTareq Al BaghdadiAjjai S AlvaStephanie A DublisTimothy L Cannon Carmen J CalfaRui LiDeepti BehlVi K ChiuPhilip J GoldAlissa S Marr Kathryn F Mileham Steven Francis Powell Jordi Rodon Ahnert Ramya Thota Gina N GranthamAbigail GregoryDominique C HinshawSusan Halabi Richard L Schilsky

Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)

Pembrolizumab demonstrated antitumor activity in pretreated patients with advanced cancers and HTMB.

Keyphrases

cancer therapy

risk factors

childhood cancer